
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Life, death, and autophagy in cancer: NF-κB turns up everywhere
Daniela Verzella, Alessandra Pescatore, Daria Capece, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 263
Daniela Verzella, Alessandra Pescatore, Daria Capece, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 263
Showing 1-25 of 263 citing articles:
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 485
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 485
Coxiella burnetii inhibits host immunity by a protein phosphatase adapted from glycolysis
Yong Zhang, Jiaqi Fu, Shuxin Liu, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 204
Yong Zhang, Jiaqi Fu, Shuxin Liu, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 204
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
Felix Weiß, Douglas A. Lauffenburger, Peter Friedl
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 157-173
Open Access | Times Cited: 191
Felix Weiß, Douglas A. Lauffenburger, Peter Friedl
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 157-173
Open Access | Times Cited: 191
Mechanism of interaction between autophagy and apoptosis in cancer
Shreya Das, Nidhi Shukla, Shashi Shekhar Singh, et al.
APOPTOSIS (2021) Vol. 26, Iss. 9-10, pp. 512-533
Closed Access | Times Cited: 172
Shreya Das, Nidhi Shukla, Shashi Shekhar Singh, et al.
APOPTOSIS (2021) Vol. 26, Iss. 9-10, pp. 512-533
Closed Access | Times Cited: 172
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 94
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 94
Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Celia Andrés, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2600-2600
Open Access | Times Cited: 37
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Celia Andrés, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2600-2600
Open Access | Times Cited: 37
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
Wamidh H. Talib, Dima Awajan, Abdelrahim Alqudah, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 29
Wamidh H. Talib, Dima Awajan, Abdelrahim Alqudah, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 29
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure
Stefan Zwirner, Anan Abu Rmilah, Sabrina Klotz, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1666-1684.e26
Open Access | Times Cited: 22
Stefan Zwirner, Anan Abu Rmilah, Sabrina Klotz, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1666-1684.e26
Open Access | Times Cited: 22
Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 21
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 21
Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells
Ce Luo, Rui Zhang, Rui Guo, et al.
Immunity (2025)
Closed Access | Times Cited: 2
Ce Luo, Rui Zhang, Rui Guo, et al.
Immunity (2025)
Closed Access | Times Cited: 2
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
Vinodh Kannappan, Misha Ali, Benjamin Small, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 92
Vinodh Kannappan, Misha Ali, Benjamin Small, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 92
Autophagy, the innate immune response and cancer
Chelsea Gerada, Kevin M. Ryan
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 1913-1929
Open Access | Times Cited: 80
Chelsea Gerada, Kevin M. Ryan
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 1913-1929
Open Access | Times Cited: 80
Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?
Violetta Krajka‐Kuźniak, Wanda Baer‐Dubowska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8223-8223
Open Access | Times Cited: 76
Violetta Krajka‐Kuźniak, Wanda Baer‐Dubowska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8223-8223
Open Access | Times Cited: 76
Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance
Chune Ren, Xue Han, Chao Lü, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 2, pp. 381-392
Open Access | Times Cited: 69
Chune Ren, Xue Han, Chao Lü, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 2, pp. 381-392
Open Access | Times Cited: 69
Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis
Bo-Ram Jin, Kyung-Sook Chung, Soonjae Hwang, et al.
Neoplasia (2021) Vol. 23, Iss. 6, pp. 561-573
Open Access | Times Cited: 56
Bo-Ram Jin, Kyung-Sook Chung, Soonjae Hwang, et al.
Neoplasia (2021) Vol. 23, Iss. 6, pp. 561-573
Open Access | Times Cited: 56
Tannic acid antagonizes atrazine exposure-induced autophagy and DNA damage crosstalk in grass carp hepatocytes via NO/iNOS/NF-κB signaling pathway to maintain stable immune function
Meichen Gao, Naixi Yang, Yutian Lei, et al.
Fish & Shellfish Immunology (2022) Vol. 131, pp. 1075-1084
Closed Access | Times Cited: 53
Meichen Gao, Naixi Yang, Yutian Lei, et al.
Fish & Shellfish Immunology (2022) Vol. 131, pp. 1075-1084
Closed Access | Times Cited: 53
The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art
Xue Zhen Wang, Lei Xia, Xiaoyu Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112800-112800
Open Access | Times Cited: 48
Xue Zhen Wang, Lei Xia, Xiaoyu Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112800-112800
Open Access | Times Cited: 48
Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals
Lixia Dong, Jingqiu He, Li Luo, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 92-92
Open Access | Times Cited: 38
Lixia Dong, Jingqiu He, Li Luo, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 92-92
Open Access | Times Cited: 38
Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer
Mohd Suhail, Mohd Rehan, Mohammad Tarique, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 29
Mohd Suhail, Mohd Rehan, Mohammad Tarique, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 29
Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
Ashik Jawahar Deen, Simone Adinolfi, Jouni Härkönen, et al.
Redox Biology (2024) Vol. 69, pp. 103031-103031
Open Access | Times Cited: 12
Ashik Jawahar Deen, Simone Adinolfi, Jouni Härkönen, et al.
Redox Biology (2024) Vol. 69, pp. 103031-103031
Open Access | Times Cited: 12
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Raffaele Strippoli, Reyhaneh Niayesh‐Mehr, Maryam Adelipour, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 807-807
Open Access | Times Cited: 12
Raffaele Strippoli, Reyhaneh Niayesh‐Mehr, Maryam Adelipour, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 807-807
Open Access | Times Cited: 12
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
Sarah T. Diepstraten, Yuan Yin, John E. La Marca, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 850-868.e9
Open Access | Times Cited: 12
Sarah T. Diepstraten, Yuan Yin, John E. La Marca, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 850-868.e9
Open Access | Times Cited: 12
Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line
Radwa Fawzy, Amal AbdEl-Aziz, Khalid Bassiouny, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100339-100339
Open Access | Times Cited: 10
Radwa Fawzy, Amal AbdEl-Aziz, Khalid Bassiouny, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100339-100339
Open Access | Times Cited: 10
Disulfiram: A novel repurposed drug for cancer therapy
Min Zeng, Baibei Wu, Wenjie Wei, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 12, pp. 1389-1398
Open Access | Times Cited: 10
Min Zeng, Baibei Wu, Wenjie Wei, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 12, pp. 1389-1398
Open Access | Times Cited: 10
NF-κB role on tumor proliferation, migration, invasion and immune escape
Afrasyab Khan, Yao Zhang, Ningna Ma, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1599-1610
Closed Access | Times Cited: 10
Afrasyab Khan, Yao Zhang, Ningna Ma, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1599-1610
Closed Access | Times Cited: 10